Antigenic cartography of SARS-CoV-2 reveals that Omicron BA.1 and BA.2 are antigenically distinct

Science immunology - Tập 7 Số 75 - 2022
Anna Z. Mykytyn1, Melanie Rissmann1, Adinda Kok1, Miruna E. Rosu1, Debby Schipper1, Tim I. Breugem1, Petra B. van den Doel1, Felicity Chandler1, Theo M. Bestebroer1, Maurice de Wit2, Martin E. van Royen3, Richard Molenkamp1, Bas B. Oude Munnink1, Rory D. de Vries1, Corine H. GeurtsvanKessel1, Derek J. Smith4, Marion Koopmans1, Barry Rockx1, Mart M. Lamers1, Ron A. M. Fouchier1, Bart L. Haagmans1
1Viroscience Department, Erasmus Medical Center, Rotterdam, Netherlands.
2Department of Neurology, Erasmus University Medical Center, Rotterdam, Netherlands
3Department of Pathology, Erasmus University Medical Center, Rotterdam, Netherlands
4Center for Pathogen Evolution, Department of Zoology, University of Cambridge, Cambridge CB2 3EJ, UK.

Tóm tắt

The emergence and rapid spread of SARS-CoV-2 variants may affect vaccine efficacy substantially. The Omicron variant termed BA.2, which differs substantially from BA.1 based on genetic sequence, is currently replacing BA.1 in several countries, but its antigenic characteristics have not yet been assessed. Here, we used antigenic cartography to quantify and visualize antigenic differences between early SARS-CoV-2 variants (614G, Alpha, Beta, Gamma, Zeta, Delta, and Mu) using hamster antisera obtained after primary infection. We first verified that the choice of the cell line for the neutralization assay did not affect the topology of the map substantially. Antigenic maps generated using pseudo-typed SARS-CoV-2 on the widely used VeroE6 cell line and the human airway cell line Calu-3 generated similar maps. Maps made using authentic SARS-CoV-2 on Calu-3 cells also closely resembled those generated with pseudo-typed viruses. The antigenic maps revealed a central cluster of SARS-CoV-2 variants, which grouped on the basis of mutual spike mutations. Whereas these early variants are antigenically similar, clustering relatively close to each other in antigenic space, Omicron BA.1 and BA.2 have evolved as two distinct antigenic outliers. Our data show that BA.1 and BA.2 both escape vaccine-induced antibody responses as a result of different antigenic characteristics. Thus, antigenic cartography could be used to assess antigenic properties of future SARS-CoV-2 variants of concern that emerge and to decide on the composition of novel spike-based (booster) vaccines.

Từ khóa


Tài liệu tham khảo

World Health Organization “Numerical data from WHO coronavirus (COVID-19) dashboard”; https://covid19.who.int.

10.1016/j.cell.2020.06.043

10.1016/j.chom.2021.02.020

10.2807/1560-7917.ES.2021.26.24.2100509

10.1016/S1473-3099(21)00170-5

10.1038/s41586-021-03944-y

10.1038/s41586-021-03402-9

World Health Organization “Tracking SARS-Cov-2 variants ” 2022 https://www.who.int/en/activities/tracking-SARS-CoV-2-variants/ [accessed 10 February 2022].

National Center for Immunization and Respiratory Diseases (NCIRD) Division of viral diseases in CDC COVID-19 Science Briefs (Centers for Disease Control and Prevention 2020).

10.1038/s41591-021-01318-5

10.1016/j.cell.2021.03.036

10.1056/NEJMc2114706

10.1038/s41586-021-03777-9

10.1126/sciimmunol.abo2202

10.1038/s41586-021-04389-z

10.1038/s41586-021-04387-1

10.1056/NEJMc2119236

10.1016/j.cell.2021.12.046

10.1016/S0140-6736(22)00017-4

10.1038/s41577-022-00678-4

W. R. Gallaher “Omicron is a multiply recombinant set of variants that have evolved over many months ” 2022; https://virological.org/t/omicron-is-a-multiply-recombinant-set-of-variants-that-have-evolved-over-many-months/775 [accessed 18 February 2022].

Freunde von GISAID “GISAID - hCov19 variants ” 2022; https://www.gisaid.org/hcov19-variants [accessed 18 February 2022].

10.1016/S1473-3099(22)00224-9

10.1038/s41591-022-01792-5

10.1056/NEJMc2201849

10.1637/8740-032509-ResNote.1

10.1006/jtbi.2001.2347

10.1038/s41586-022-04441-6

10.1038/s41586-020-2787-6

10.1038/s41586-020-2342-5

10.1126/science.1097211

10.7554/eLife.64508

M. M. Lamers A. Z. Mykytyn T. I. Breugem N. Groen K. Knoops D. Schipper R. van Acker P. B. van den Doel T. Bestebroer C. D. Koopman C. Reusken M. J. Muraro C. H. GeurtsvanKessel M. E. van Royen P. J. Peters J. Zhang B. L. Haagmans SARS-CoV-2 Omicron efficiently infects human airway but not alveolar epithelium. bioRxiv 2022.01.19.476898 [Preprint]. 20 January 2022. https://doi.org/10.1101/2022.01.19.476898.

10.1046/j.1365-2672.2001.01492.x

S. H. Wilks B. Mühlemann X. Shen S. Türeli E. B. LeGresley A. Netzl M. A. Caniza J. N. Chacaltana-Huarcaya X. Daniell M. B. Datto T. N. Denny C. Drosten R. A. M. Fouchier P. J. Garcia P. J. Halfmann A. Jassem T. C. Jones Y. Kawaoka F. Krammer C. McDanal R. Pajon V. Simon M. Stockwell H. Tang H. van Bakel R. Webby D. C. Montefiori D. J. Smith Mapping SARS-CoV-2 antigenic relationships and serological responses. bioRxiv 2022.01.28.477987 [Preprint]. 28 January 2022. https://doi.org/10.1101/2022.01.28.477987.

10.1371/journal.pone.0258513

10.3389/fpubh.2021.775224

10.2807/1560-7917.ES.2021.26.16.2100348

10.1126/science.abc1669

10.2807/1560-7917.ES.2020.25.3.2000045